The 5.5 mL syringe is currently in development with samples for feasibility studies expected to be available in mid-2026. Within the same timeframe, Ypsomed plans to expand the YpsoMate 5.5 platform ...
Demand spurs innovations in syringes and syringe fill/finish operations. The intense pressure to develop vaccines and treatments for COVID-19 has helped spur strong growth in the pre-filled syringe ...
In a safety alert issued August 18, the FDA said compounded or repackaged drugs that have been stored in 3- and 5-mL syringes manufactured by Becton-Dickinson should not be administered to patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results